168 related articles for article (PubMed ID: 34888903)
1. Letter to the editor: Reactivation of HBV triggered by SARS-CoV-2 in a patient with cirrhosis.
Librero Jiménez M; López Garrido MÁ; Fernández Cano MC
Hepatology; 2022 Mar; 75(3):765-766. PubMed ID: 34888903
[No Abstract] [Full Text] [Related]
2. Genotype Matters in Patients with Acute-on-chronic Liver Failure Due to Reactivation of Chronic Hepatitis B.
Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y
Clin Transl Gastroenterol; 2018 Nov; 9(11):202. PubMed ID: 30416197
[TBL] [Abstract][Full Text] [Related]
3. Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?
Lei JH; Peng F; Chen Z; Xiao XQ
BMC Infect Dis; 2019 Apr; 19(1):363. PubMed ID: 31039732
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C.
Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Wu XN; Yang JH
J Clin Gastroenterol; 2019 Apr; 53(4):e171-e177. PubMed ID: 29659382
[TBL] [Abstract][Full Text] [Related]
5. Does antiviral therapy reduce complications of cirrhosis?
Chung GE; Lee JH; Kim YJ
World J Gastroenterol; 2014 Jun; 20(23):7306-11. PubMed ID: 24966601
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients.
Chung GE; Cho EJ; Lee JH; Yoo JJ; Lee M; Cho Y; Lee DH; Kim HY; Yu SJ; Kim YJ; Yoon JH; Zoulim F
Clin Mol Hepatol; 2017 Mar; 23(1):66-73. PubMed ID: 28190329
[TBL] [Abstract][Full Text] [Related]
7. Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana.
Stockdale AJ; Phillips RO; Beloukas A; Appiah LT; Chadwick D; Bhagani S; Bonnett L; Sarfo FS; Dusheiko G; Geretti AM;
Clin Infect Dis; 2015 Sep; 61(6):883-91. PubMed ID: 26021992
[TBL] [Abstract][Full Text] [Related]
8. Liver Fibrosis Reversion After Suppression of Hepatitis B Virus.
Rockey DC
Clin Liver Dis; 2016 Nov; 20(4):667-679. PubMed ID: 27742006
[TBL] [Abstract][Full Text] [Related]
9. The impact of HBV flare on the outcome of HBV-related decompensated cirrhosis patients with bacterial infection.
Cao Z; Liu Y; Wang S; Lu X; Yin S; Jiang S; Chen L; Cai M; Zeng B; Yao Y; Tang W; Zhao G; Xiang X; Wang H; Cai W; Zhu C; Li H; Xie Q
Liver Int; 2019 Oct; 39(10):1943-1953. PubMed ID: 31206235
[TBL] [Abstract][Full Text] [Related]
10. Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
Zhang Y; Hu XY; Zhong S; Yang F; Zhou TY; Chen G; Wang YY; Luo JX
World J Gastroenterol; 2014 Apr; 20(16):4745-52. PubMed ID: 24782628
[TBL] [Abstract][Full Text] [Related]
11. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.
Preda CM; Popescu CP; Baicus C; Constantinescu I; Oproiu A; Voiosu T; Diculescu M; Negreanu L; Gheorghe L; Sporea I; Trifan A; Ceausu E; Proca D; Manuc M
J Viral Hepat; 2018 Jul; 25(7):834-841. PubMed ID: 29397016
[TBL] [Abstract][Full Text] [Related]
12. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
[TBL] [Abstract][Full Text] [Related]
13. Cirrhosis has no impact on therapeutic responses of entecavir for chronic hepatitis B.
Wang PC; Wei TY; Tseng TC; Lin HH; Wang CC
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):946-950. PubMed ID: 28538267
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients.
Jung SK; Kim KA; Ha SY; Lee HK; Kim YD; Lee BH; Paik WH; Kim JW; Bae WK; Kim NH; Lee JS; Jwa YJ
Clin Mol Hepatol; 2015 Mar; 21(1):41-8. PubMed ID: 25834801
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 as a Trigger of Acute-on-Chronic Hepatitis B Presenting With Undetectable INR Due to Hypercoagulability in a 16-Year-Old Girl.
Giugliano L; Pinon M; Calvo PL
Pediatr Infect Dis J; 2023 Feb; 42(2):143-145. PubMed ID: 36638401
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of hepatitis B virus mutations in 20 patients with HBV-related acute-on-chronic liver failure and 19 patients with chronic hepatitis B].
Zhao Z; Han T; Gao Y; Zhang Y; Liu T; Jing L; Guo H
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):228-31. PubMed ID: 24919225
[No Abstract] [Full Text] [Related]
17. Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naïve chronic hepatitis B: A case report and review of the literature.
Cho WH; Lee HJ; Bang KB; Kim SB; Song IH
World J Gastroenterol; 2018 May; 24(17):1919-1924. PubMed ID: 29740207
[TBL] [Abstract][Full Text] [Related]
18. Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation.
Philips CA; Sarin SK
World J Gastroenterol; 2014 Nov; 20(43):16037-52. PubMed ID: 25473156
[TBL] [Abstract][Full Text] [Related]
19. A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea.
Kim SU; Seo YS; Lee HA; Kim MN; Lee YR; Lee HW; Park JY; Kim DY; Ahn SH; Han KH; Hwang SG; Rim KS; Um SH; Tak WY; Kweon YO; Kim BK; Park SY
J Hepatol; 2019 Sep; 71(3):456-464. PubMed ID: 30959156
[TBL] [Abstract][Full Text] [Related]
20. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
Garg H; Sarin SK; Kumar M; Garg V; Sharma BC; Kumar A
Hepatology; 2011 Mar; 53(3):774-80. PubMed ID: 21294143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
